Labcorp Holdings Stock Drops Amid Medicare Reimbursement Rate Reduction
On September 22, 2026, Labcorp Holdings (NYSE: LH) stock fell by approximately 3.3% after the Centers for Medicare & Medicaid Services (CMS) announced a plan to reduce reimbursement rates for lab work starting January 1, 2027. The new policy will cut CMS payments by up to 15%, which is expected to save taxpayers $1 billion annually but could significantly impact Labcorp's revenue. Labcorp reported that approximately 8% of its total revenue in 2025 came from Medicare and Medicaid reimbursements, meaning a full 15% reduction would result in an estimated annual decline of about 1.2%. The company has warned investors that successive reductions over the next three years could lead to up to a 3.6% drop in overall business performance. The stock's sharp decline suggests market participants have already priced in this worst-case scenario, potentially limiting further downward pressure on Labcorp shares.
Topics: CMS reimbursement rates Labcorp revenue impact stock price drop